341![Microsoft Word - ReleaseNotesScriptBase406.doc Microsoft Word - ReleaseNotesScriptBase406.doc](https://www.pdfsearch.io/img/10f6d632732f5c967a587643d87fa767.jpg) | Add to Reading ListSource URL: www.scriptbase.co.ukLanguage: English - Date: 2010-01-28 07:49:53
|
---|
342![Medication Guide SUBOXONE® (Sub-OX-own) Medication Guide SUBOXONE® (Sub-OX-own)](https://www.pdfsearch.io/img/9e0f9e4cd0592a3949ba4245a4d24c40.jpg) | Add to Reading ListSource URL: www.suboxone.comLanguage: English - Date: 2013-12-03 11:48:53
|
---|
343![MEDICATION GUIDE SUBOXONE® (Sub-OX-own) (buprenorphine and naloxone) MEDICATION GUIDE SUBOXONE® (Sub-OX-own) (buprenorphine and naloxone)](https://www.pdfsearch.io/img/751331992a01a3516326646d5b308b58.jpg) | Add to Reading ListSource URL: www.suboxone.comLanguage: English - Date: 2014-04-29 17:23:15
|
---|
344![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUBOXONE safely and effectively. See full prescribing information for SUBOXONE. SUBOXONE® (buprenorphine and naloxo HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUBOXONE safely and effectively. See full prescribing information for SUBOXONE. SUBOXONE® (buprenorphine and naloxo](https://www.pdfsearch.io/img/d817195d71a867d7adf8a88b030eeada.jpg) | Add to Reading ListSource URL: www.suboxone.comLanguage: English - Date: 2014-04-29 17:23:15
|
---|
345![INDICATION SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine indicated for treatment of opioid dependence and should be used as part of a complete INDICATION SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine indicated for treatment of opioid dependence and should be used as part of a complete](https://www.pdfsearch.io/img/3e5ff2a37635aba0fde83a6e52689b1f.jpg) | Add to Reading ListSource URL: www.suboxone.comLanguage: English - Date: 2014-04-29 17:23:15
|
---|
346![PCSS Guidance Topic: Monitoring of liver function tests and hepatitis in patients receiving buprenorphine/naloxone PCSS Guidance Topic: Monitoring of liver function tests and hepatitis in patients receiving buprenorphine/naloxone](https://www.pdfsearch.io/img/7c330e2e0820c7e3023b2b18b57abc49.jpg) | Add to Reading ListSource URL: www.naabt.orgLanguage: English - Date: 2013-10-29 08:32:54
|
---|
347![DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service](https://www.pdfsearch.io/img/72511a889d54d3a5deb8fb3663e48769.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-04-01 17:20:15
|
---|
348![Precipitated withdrawal buprenorphine Precipitated withdrawal buprenorphine](https://www.pdfsearch.io/img/c024c731a2aca3db04cab2e78ee3b06f.jpg) | Add to Reading ListSource URL: www.naabt.orgLanguage: English - Date: 2011-11-28 16:35:47
|
---|